Cleared Special

K092423 - XPECT FLU A & B (FDA 510(k) Clearance)

Aug 2009
Decision
19d
Days
Class 2
Risk

K092423 is an FDA 510(k) clearance for the XPECT FLU A & B. This device is classified as a Devices Detecting Influenza A, B, And C Virus Antigens (Class II - Special Controls, product code PSZ).

Submitted by Thermo Fisher Scientific (Lenexa, US). The FDA issued a Cleared decision on August 26, 2009, 19 days after receiving the submission on August 7, 2009.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3328. An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection..

Submission Details

510(k) Number K092423 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 07, 2009
Decision Date August 26, 2009
Days to Decision 19 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PSZ — Devices Detecting Influenza A, B, And C Virus Antigens
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3328
Definition An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection.